Rob Torrance

PhD student in Cell & Gene Therapy @iit_ucl

Interested in translating basic science into clinical benefit for patients!

[Nature Communications @NatureComms]

People might be catching avian flu from wild birds, study suggests

Scientists uncover evidence in the jungles of Borneo suggesting migratory birds can infect people directly

@hannahjklim @Carroll_Lab_Ox @PSIOxford @HumanGeneticsOx

#avianflu #H5N1

https://t.co/2EfMqadANP

[Carroll Lab @Carroll_Lab_Ox]

New paper led by our former DPhil student @hannahjklim out now in @NatureComms ‘Serological analysis in humans in Malaysian Borneo suggests prior exposure to H5 avian influenza near migratory shorebird habitats’

Some media coverage in the thread below

https://t.co/HvV5ybdGlg

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapy https://t.co/HuigWfbgxg @helena_are @Peppa_Group

[The Nobel Prize @NobelPrize]

BREAKING NEWS
The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

[IIT @iit_ucl]

Thrilled to have Her Majesty The Queen visit @iit_ucl to hear about the type 1 diabetes research in Professor Lucy Walker’s lab. Her Majesty is president of JDRF who fund ground-breaking research aiming to cure this condition. @uclnews @UCLInfectImm

https://t.co/TBUhGXZ8kb

[Adriana Albuquerque @adrialb]

Our paper describing a STAT-6 gain of function mutation in association with severe atopy and lymphoma is out.
@iit_ucl @UCLInfectImm
#primaryimmunodefiency
#RareDisease
#PID

https://t.co/TfVL1zcWtf

[Adriana Albuquerque @adrialb]

Happy to share our latest paper describing a novel syndrome causing multi-organ autoimmunity due to mutations in the SH2B3 gene.

@iit_ucl @UCLInfectImm

#primaryimmunodeficiency #RareDisease #PID

https://t.co/mqxs3PKLyv

[Adriana Albuquerque @adrialb]

Excited to share that our new study describing 5 new variants of unknown significance in the STAT1 gene is out. #PID #PrimaryImmunodefiency #STAT1 #RareDiseases

Practical challenges for functional validation of STAT1 gain of function genetic variants https://t.co/0Ja5LFHzx1

[Prof Emma Morris 💙 @ecmorris]

UCL named key strategic partner in EU’s new ‘Centre for the Technologies of Gene and Cell Therapy’ | UCL News - UCL – University College London https://t.co/NAc1VyweWX

Fantastic news and what promises to be an exciting, collaborative venture with our European friends 🍾🙌👏

[Blood Cancer UK @bloodcancer_uk]

This Christmas you can make a huge difference to the 40,000 people diagnosed with blood cancer in the UK 🎁

🏷️ Because research is saving lives
🏷️ Because we WILL beat blood cancer
🏷️ Because it's Christmas!

Please donate and give the gift of hope 👇
https://t.co/buOSqSNIfN

[Prof Emma Morris 💙 @ecmorris]

Therapeutic gene editing of T cells to correct CTLA-4 insufficiency https://t.co/WfSINjTTSx

Our new paper - out today! @RealDrfox fabulous science. @iit_ucl @uclmedsci @LucyWalkerlab @UCLInfectImm and massive thanks to Prof Claire Booth, Dr Pietro Genoese & Prof David Samson.

[UK Research and Innovation @UKRI_News]

NEW: We're increasing our minimum student stipend by 10% from 1 October 2022. Full details: https://t.co/hhmtX95OVW

[Frontiers - Immunology @FrontImmunol]

New Research: Lentiviral Mediated ADA2 Gene Transfer Corrects the Defects Associated With Deficiency of Adenosine Deaminase Type 2: Deficiency of adenosine deaminase type 2 (DADA2) is an autosomal recessive disease caused by bi-allelic… https://t.co/6dBpr3uMFa #immunology